Family Medicine · Gadsden, AL
NPI
1871593566
Since 2005
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
307 E Meighan Blvd
Gadsden, AL, 35903
Phone (256) 543-2273
Groups this clinician bills Medicare through
Medicare paid, 2024
$52K
1,872 services
Medicare patients, 2024
297
Average age 74
Drug cost, 2024
$823K
8,734 prescriptions
Company payments, 2025
$390
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Roger S Buck was code J0702 (injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg), 265 times for 87 patients. In total Roger S Buck billed 1,872 services in 56 codes, and Medicare paid $52K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-06-10.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 265 | 87 | $4.59 | $1,217 |
| 99214 Office E&M - Established | Office | 220 | 191 | $81.05 | $18K |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 215 | 82 | $0.32 | $69.08 |
| 96372 Injection Administration | Office | 210 | 121 | $9.23 | $1,939 |
| 81000 Clinical Chemistry | Office | 109 | 98 | $3.87 | $422 |
| 85025 Blood Count | Office | 101 | 99 | $7.46 | $753 |
| 99497 Care Management/Coordination | Office | 69 | 69 | $77.78 | $5,367 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 66 | 66 | $18.05 | $1,191 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 66 | 66 | $126.27 | $8,334 |
| 82570 Clinical Chemistry | Office | 60 | 60 | $5.08 | $305 |
| 82043 Clinical Chemistry | Office | 60 | 60 | $5.66 | $340 |
| J2010 Injection, lincomycin hcl, up to 300 mg | Office | 48 | 23 | $5.83 | $280 |
| 87804 Immunoassay | Office | 46 | 23 | $16.22 | $746 |
| 87811 Immunoassay | Office | 38 | 37 | $40.55 | $1,541 |
| 99204 Office E&M - New | Office | 31 | 31 | $103.28 | $3,202 |
By year: 2022 $50K for 1,628 services; 2023 $53K for 1,913 services; 2024 $52K for 1,872 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81000 Clinical Chemistry | 109 | 98 | $3.87 | $422 |
| 85025 Blood Count | 101 | 99 | $7.46 | $753 |
| 82043 Clinical Chemistry | 60 | 60 | $5.66 | $340 |
| 82570 Clinical Chemistry | 60 | 60 | $5.08 | $305 |
| 87804 Immunoassay | 46 | 23 | $16.22 | $746 |
| 87811 Immunoassay | 38 | 37 | $40.55 | $1,541 |
| 83036 Blood Count | 25 | 25 | $9.14 | $228 |
Medicare prescription drug claims, 2024
In 2024, the drug Roger S Buck prescribed most often to Medicare patients was Atorvastatin Calcium, with 368 prescriptions and refills. In total Roger S Buck wrote 8,734 Medicare prescriptions that cost $823K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 368 | 1,050 | 118 | $4,323 |
| Gabapentin Generic | 276 | 401 | 68 | $2,775 |
| Amlodipine Besylate Generic | 251 | 724 | 100 | $2,245 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 228 | 258 | 69 | $7,262 |
| Clonazepam Generic | 217 | 236 | 32 | $1,310 |
| Levothyroxine Sodium Generic | 215 | 527 | 64 | $2,746 |
| Rosuvastatin Calcium Generic | 199 | 580 | 89 | $3,572 |
| Omeprazole Generic | 188 | 510 | 65 | $2,710 |
| Losartan Potassium Generic | 187 | 509 | 75 | $2,460 |
| Lisinopril Generic | 183 | 509 | 71 | $1,373 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 180 | 180 | 37 | $2,512 |
| Pantoprazole Sodium Generic | 177 | 436 | 64 | $2,422 |
| Carvedilol Generic | 154 | 357 | 45 | $2,012 |
| Azithromycin Generic | 135 | 135 | 123 | $1,263 |
| Lorazepam Generic | 132 | 140 | 18 | $535 |
Brand drugs: 945 claims; generic drugs: 7,732 claims; opioid claims: 327.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Roger S Buck $390 ($390 in general payments such as food, travel and fees) from 9 companies. The largest payer was Pfizer Inc. with $103.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 6 | $103 |
| Madrigal Pharmaceuticals MDGL | 1 | $84.2 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $49.68 |
| GlaxoSmithKline, LLC. GSK | 2 | $36.06 |
| Abbvie Inc. ABBV | 2 | $30.46 |
| Exact Sciences Corporation EXAS | 2 | $29.63 |
| Amgen Inc. AMGN | 2 | $28.08 |
| Novo Nordisk Inc NVO | 1 | $15.03 |
| Phathom Pharmaceuticals, Inc. PHAT | 1 | $13.47 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.